Small Animal Internal Medicine
Dr. Yoko Ambrosini is a Small Animal Medicine resident who graduated from Nihon University in Japan. After veterinary school, she completed a Master in Preventive Veterinary Medicine, then a PhD in Comparative Pathology at UCDavis. She completed a rotating internship at Veterinary Specialty Hospital in San Diego, CA, and an Internal Medicine internship at Animal Specially Group in Los Angeles, CA. Dr. Ambrosini’s special interests include hepatology, gastroenterology, nephrology, endocrinology, and immunology. Her hobbies include yoga, traveling, and cooking. When not at work, she spends time with her husband, two daughters, and a cat, Edgie.
- PhD – University of California, Davis, 2011
- MPVM – University of California, Davis, 2009
- BVM and DVM – Nihon University, 2007
The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis
Ambrosini YM, Yang GX, Zhang W, Tsuda M, Shu SA, Tsuneyama K, Leung PS, Ansari AA, Coppel RL, Gershwin ME. Clin Exp Immunol. 2011 Oct;166(1):110-20. Impact Factor: 3.41
Fine phenotypic and functional characterization of effector CD8(+) T cells in patients with primary biliary cirrhosis.
Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, Tsuneyama K, Sumida K, Shimoda S, Bowlus CL, Leung PS, He XS, Coppel RL, Ansari AA, Lian ZX, Gershwin ME. Hepatology. 2011 Jul 6. Impact Factor: 11.665
Risk factors and prediction of long-term outcome in primary biliary cirrhosis.
Ishibashi H, Komori A, Shimoda S, Ambrosini YM, Gershwin ME, Nakamura M.
Intern Med. 2011;50(1):1-10. Impact Factor: 0.936
Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow--bone marrow transplantation plus concurrent thymic transplantation.
Li M, Abraham NG, Vanella L, Zhang Y, Inaba M, Hosaka N, Hoshino S, Shi M, Ambrosini YM, Gershwin ME, Ikehara S. J Autoimmun. 2010 Dec;35(4):414-23. Impact Factor: 7.368
Murine models of autoimmune cholangitis.
Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME.
Curr Opin Gastroenterol. 2010 May;26(3):274-9. Impact Factor: 0.936
General Research Interests